Title |
GILZ as a Mediator of the Anti-Inflammatory Effects of Glucocorticoids
|
---|---|
Published in |
Frontiers in endocrinology, November 2015
|
DOI | 10.3389/fendo.2015.00170 |
Pubmed ID | |
Authors |
Simona Ronchetti, Graziella Migliorati, Carlo Riccardi |
Abstract |
Glucocorticoid-induced leucine zipper (GILZ) is a dexamethasone-inducible gene that mediates glucocorticoid (GC) actions in a variety of cell types, including many cells of immune system. In particular, GILZ can control T cell activities, such as activation and differentiation, mainly through its ability to homo- and hetero-dimerize with partner proteins, such as NF-κB, Ras, and C/EBP. These protein-protein interactions control the regulation of pro-inflammatory target genes. A number of in vitro and in vivo studies using mouse models of inflammatory diseases demonstrate an anti-inflammatory role for GILZ. Here, authors summarize the studies that make GILZ eligible as an anti-inflammatory protein through which GCs can act. These findings permit the future development of pharmacological tools that mimic the therapeutic effects of GCs while avoiding the detrimental ones. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 124 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 26 | 21% |
Student > Master | 22 | 18% |
Researcher | 17 | 14% |
Student > Bachelor | 13 | 10% |
Student > Doctoral Student | 7 | 6% |
Other | 13 | 10% |
Unknown | 26 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 32 | 26% |
Agricultural and Biological Sciences | 21 | 17% |
Medicine and Dentistry | 13 | 10% |
Immunology and Microbiology | 12 | 10% |
Neuroscience | 7 | 6% |
Other | 10 | 8% |
Unknown | 29 | 23% |